From Corona Virus to Heartache: Investigating Acute Pericarditis after Covid-19
Abstract
Cardiovascular disorders have been associated with coronavirus disease 2019 (COVID-19). One of the emerging complications is acute pericarditis, characterized by inflammation of the pericardium. Pericarditis is a complication that arises after COVID-19 infection because the virus can cause widespread inflammation, including in the pericardium, the outer layer of the heart. Risk factors that may exacerbate pericarditis in COVID-19 patients include the severity of COVID-19 disease, an immunocompromised state, or an excessive immune system response to infection. The aim of the study is to describe a case of acute pericarditis that occurred after Severe Acute Respiratory Syndrom - Coronavirus 2 (SARS-CoV-2) infection. This study used a case study design. This study was conducted on one of the patients who experienced pericarditis after Covid-19. Researchers conducted nursing assessments and analyzed nursing data. Data analysis was carried out descriptively to describe the results of nursing assessment. A few days after experiencing SARS-CoV-2 pneumonia, 51-year-old Mr. S. developed chest pain that became more painful during exertion, and received a diagnosis of acute pericarditis. As a result, medical treatment was escalated with clinical improvement continuing to improve. Electrocardiography showed elevation in ST segment and depression in PR interval. Echocardiography showed grade I diastolic phase disruption. Acute pericarditis is a rare complication following viral infection. This report shows the assessment and management of acute pericarditis so as to prevent complications that can occur.
References
Adler, Y., Charron, P., Imazio, M., Badano, L., Barón-Esquivias, G., Bogaert, J., Nesukay, E. (2015). 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. European Heart Journal,36(42), 2921-2964. https://doi.org/10.1093/eurheartj/ehv318
Anastassopoulou, C., Hatziantoniou, S., & Vlachopoulos, C. (2022). Temporal relationship of myocarditis and pericarditis following COVID-19 vaccination: a pragmatic approach. Int J Cardiol, 358. https://doi.org/10.1016/j.ijcard.2022.04.024
Buckley, B. J. R., Harrison, S. L., & Fazio-Eynullayeva, E. (2021). Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur J Clin Invest, 51. https://doi.org/10.1111/eci.13679
Crowe, S., Cresswell, K., Robertson, A., Huby, G., Avery, A., & Sheikh, A. (2011). The case study approach. https://doi.org/10.1186/1471-2288-11-100
Cvetko, T. T., Ljubic, J., & Ostricki, B. (2023). Purulent pericarditis caused by methicillin-sensitive Staphylococcus aureus in an immunocompetent adult after COVID-19 pneumonia: a case report. European Heart Journal - Case Reports, 7(4). https://doi.org/10.1093/ehjcr/ytad141
Diaz, G. A. (2021). Myocarditis and pericarditis after vaccination for COVID-19. JAMA, 326. https://doi.org/10.1001/jama.2021.13443
Dini, F. L., Baldini, U., Bytyçi, I., Pugliese, N. R., Bajraktari, G., & Henein, M. Y. (2023). Acute pericarditis as a major clinical manifestation of long COVID-19 syndrome. International Journal of Cardiology, 374, 129–134. https://doi.org/10.1016/j.ijcard.2022.12.019
Dixit, N. M., Churchill, A., Nsair, A., & Hsu, J. J. (2021). Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? In American Heart Journal Plus: Cardiology Research and Practice (Vol. 5). Elsevier Inc. https://doi.org/10.1016/j.ahjo.2021.100025
Domínguez, D. R., Cid, A. R., Campos Fernández, C., Almela, C. M., José, J., Garrido, L., & Dolores, M. (2023). Recurrent pericarditis after Covid-19 Pericarditis efusivo-constrictiva recidivante tras COVID-19. In Reumatol Clin (Vol. 18). https://www.cureus.com/
Fairweather, D. L., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023). COVID-19, Myocarditis and Pericarditis. In Circulation Research (Vol. 132, Issue 10, pp. 1302–1319). Lippincott Williams and Wilkins. https://doi.org/10.1161/CIRCRESAHA.123.321878
Fatima, M., Ahmad Cheema, H., Ahmed Khan, M. H., Shahid, H., Saad Ali, M., Hassan, U., Wahaj Murad, M., Aemaz Ur Rehman, M., & Farooq, H. (2022). Development of myocarditis and pericarditis after COVID-19 vaccination in adult population: A systematic review. Annals of Medicine and Surgery, 76, 103486. https://doi.org/https://doi.org/10.1016/j.amsu.2022.103486
Fox, K., Prokup, J. A., Butson, K., & Jordan, K. (2020). Acute effusive pericarditis: a late complication of COVID-19. Cureus, 12. https://doi.org/10.7759/cureus.9074
Galea, N., Cundari, G., Di Dedda, E., Chimenti, C., Aquaro, G. D., Barison, A., Cau, R., Di Cesare, E., Di Renzi, P., Esposito, A., Faletti, R., Gatti, M., Liguori, C., Lovato, L., Mantini, C., Monti, C. B., Palmisano, A., Pradella, S., Ricci, F., … Francone, M. (2023). Short term outcome of myocarditis and pericarditis following COVID-19 vaccines: a cardiac magnetic resonance imaging study. The International Journal of Cardiovascular Imaging, 39(5), 1031–1043. https://doi.org/10.1007/s10554-023-02799-w
Imazio, M., Gaita, F., & LeWinter, M. (2015). Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA, 314(14), 1498-1506. https://doi.org/10.1001/jama.2015.12763
Karadeniz, H., Yamak, B. A., Özger, H. S., Sezenöz, B., Tufan, A., & Emmi, G. (2020). Anakinra for the treatment of COVID-19-associated pericarditis: a case report. Cardiovasc Drugs Ther, 34. https://doi.org/10.1007/s10557-020-07044-3
Kumar, R., Kumar, J., Daly, C., & Edroos, S. A. (2020). Acute pericarditis as a primary presentation of COVID-19. BMJ Case Rep, 13. https://doi.org/10.1136/bcr-2020-237617
Latif, A., Patel, A. D., Mahfood Haddad, T., Lokhande, C., Del Core, M., & Esterbrooks, D. (2020). Massive purulent pericarditis presenting as cardiac tamponade. Baylor University Medical Center Proceedings, 662–663. https://doi.org/10.1080/08998280.2020.1783985
Le Vu, S., Bertrand, M., Jabagi, M.-J., Botton, J., Drouin, J., Baricault, B., Weill, A., Dray-Spira, R., & Zureik, M. (2022). Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines. Nature Communications, 13(1), 3633. https://doi.org/10.1038/s41467-022-31401-5
LeWinter, M. M. (2014). Clinical practice. Acute pericarditis. N Engl J Med, 371(25), 2410-2416. https://doi.org/10.1056/NEJMcp1404070
Patone, M., Mei, X. W., Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M., Watkinson, P., Khunti, K., Harnden, A., Coupland, C. A. C., Channon, K. M., Mills, N. L., Sheikh, A., & Hippisley-Cox, J. (2022). Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature Medicine, 28(2), 410–422. https://doi.org/10.1038/s41591-021-01630-0
Talerico, G., Gligorova, S., Cicogna, F., Ciacci, P., Bellelli, V., Sabetta, F., Azzaro, G., & Calò, L. (2022). A case of transient constrictive pericarditis after COVID-19. Journal of Cardiology Cases, 26(5), 353–356. https://doi.org/10.1016/j.jccase.2022.07.006
Vosko, I., Zirlik, A., & Bugger, H. (2024). Impact of COVID-19 on Cardiovascular Disease | Enhanced Reader.
WHO. (2024). Why is COVID-19 data being presented as weekly statistics? https://data.who.int/dashboards/covid19/cases?n=c.
Copyright (c) 2024 Indonesian Journal of Global Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
